SCHEMBL571992

SCHEMBL571992

CCCC1(C(=O)O)C=Nc2ccccc21

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APEX1 P27695 1/20 0.33
THRB P10828 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
ALOX5 P09917 1/20 0.32
CNR2 P34972 2/20 0.31
HDAC4 P56524 1/20 0.31
CES2 O00748 1/20 0.31
CES1 P23141 1/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
RAB9A P51151 2/20 0.31
MAPT P10636 2/20 0.31
POLB P06746 1/20 0.31
NPC1 O15118 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2C19 P33261 1/20 0.31
KDM4E B2RXH2 1/20 0.31
GLA P06280 1/20 0.31
GAA P10253 1/20 0.31
NAAA Q02083 1/20 0.30
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27684552 0.84 PDE7A (0.31) MAPTALDH1A1
SCHEMBL5078595 0.73 PDE7A (0.31)
SCHEMBL28301722 0.71 THRB (0.39) APEX1THRBTDP1CES2CES1
SCHEMBL28313300 0.70 GSTO1 (0.32) THRBCYP2C19ALDH1A1
SCHEMBL30625890 0.70 SLC7A5 (0.41)
SCHEMBL28202397 0.68 THRB (0.37) APEX1THRBTDP1L3MBTL1LMNA
SCHEMBL4622560 0.68 THRB (0.37) APEX1THRBTDP1L3MBTL1LMNA
SCHEMBL2490028 0.66 AKR1B1 (0.39) APEX1THRBTDP1MAPTCYP2C19
SCHEMBL3916105 0.65 CYP1A2 (0.32) CYP1A2CYP2C19
SCHEMBL6187511 0.65 THRB (0.50) APEX1THRBTDP1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2646025-A1 USE OF SIGMA LIGANDS IN BONE CANCER PAIN Laboratorios Del. Dr. Esteve, S.A. (ES) 2013-10-09 EP disclosed
EP-2600863-A2 USE OF SIGMA LIGANDS IN OPIOID-INDUCED HYPERALGESIA Laboratorios Del. Dr. Esteve, S.A. (ES) 2013-06-12 EP disclosed
EP-2571501-A1 SIGMA LIGANDS FOR THE PREVENTION AND/OR TREATMENT OF EMESIS INDUCED BY CHEMOTHERAPY OR RADIOTHERAPY Laboratorios Del. Dr. Esteve, S.A. (ES) 2013-03-27 EP disclosed
EP-2531191-A1 SIGMA LIGANDS FOR USE IN THE PREVENTION AND/OR TREATMENT OF POSTOPERATIVE PAIN Laboratorios Del. Dr. Esteve, S.A. (ES) 2012-12-12 EP disclosed
WO-2012072782-A1 USE OF SIGMA LIGANDS IN BONE CANCER PAIN LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2012-06-07 WO disclosed
WO-2012016980-A2 USE OF SIGMA LIGANDS IN OPIOID-INDUCED HYPERALGESIA LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2012-02-09 WO disclosed
WO-2011144721-A1 SIGMA LIGANDS FOR THE PREVENTION AND/OR TREATMENT OF EMESIS INDUCED BY CHEMOTHERAPY OR RADIOTHERAPY LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2011-11-24 WO disclosed
WO-2011095584-A1 SIGMA LIGANDS FOR USE IN THE PREVENTION AND/OR TREATMENT OF POSTOPERATIVE PAIN LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2011-08-11 WO disclosed
CN-102018715-A Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier PHILADELPHIA HEALTH & EDUCATIO 2011-04-20 CN disclosed
CN-1674879-A Immunomodulation and effects on cellular processes involving serotonin family receptors and the blood brain barrier PHILADELPHIA HEALTH & EDUCATIO (US) 2005-09-28 CN disclosed